Literature DB >> 2645571

Taurine in pediatric nutrition: review and update.

G E Gaull1.   

Abstract

Taurine was long considered an end product of the metabolism of the sulfur-containing amino acids, methionine and cyst(e)ine. Its only clearly recognized biochemical role had been as a substrate in the conjugation of bile acids. Taurine is found free in millimolar concentrations in animal tissues, particularly those that are excitable, rich in membranes, and generate oxidants. Various lines of evidence suggest one major nutritional role as protecting cell membranes by attenuating toxic substances and/or by acting as an osmoregulator. The totality of evidence suggests that taurine is nonessential in the rodent, it is an essential amino acid in the cat, and it is conditionally essential in man and monkey. Absence from the diet of a conditionally essential nutrient does not produce immediate deficiency disease but, in the long term, can cause problems. Taurine is now added to many infant formulas as a measure of prudence to provide improved nourishment with the same margin of safety for its newly identified physiologic functions as that found in human milk. Such supplementation can be justified by the finding of improved fat absorption in preterm infants and in children with cystic fibrosis, as well as by salutary effects on auditory brainstem-evoked responses in preterm infants. Experimental findings in animal models and in human cell models provide further justification for taurine supplementation of infant formulas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645571

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

Review 1.  Energy beverages: content and safety.

Authors:  John P Higgins; Troy D Tuttle; Christopher L Higgins
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Tailoring total parenteral nutrition.

Authors:  H Parsons
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

3.  The biosynthesis of taurine fromN-acetyl-L-cysteine and other precursorsin vivo and in rat hepatocytes.

Authors:  C J Waterfield; J A Timbrell
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

4.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

5.  Taurine inhibits K+-Cl- cotransporter KCC2 to regulate embryonic Cl- homeostasis via with-no-lysine (WNK) protein kinase signaling pathway.

Authors:  Koichi Inoue; Tomonori Furukawa; Tatsuro Kumada; Junko Yamada; Tianying Wang; Rieko Inoue; Atsuo Fukuda
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 6.  Taurine in infant nutrition.

Authors:  S Karan
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

Review 7.  Regulation of the cellular content of the organic osmolyte taurine in mammalian cells.

Authors:  Ian Henry Lambert
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

8.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

9.  Metabolomics characterization of colostrum in three sow breeds and its influences on piglets' survival and litter growth rates.

Authors:  Gianfranco Picone; Martina Zappaterra; Diana Luise; Alessia Trimigno; Francesco Capozzi; Vincenzo Motta; Roberta Davoli; Leonardo Nanni Costa; Paolo Bosi; Paolo Trevisi
Journal:  J Anim Sci Biotechnol       Date:  2018-03-07

Review 10.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.